Investors

Investors

We are a life science technology company leveraging novel next generation sequencing (NGS) and multiomics technologies to build products that empower researchers and clinicians.

News

Jan 10, 2022

Singular Genomics Partners with Twist Bioscience to Enable the Twist NGS Target Enrichment Solutions for the G4 Sequencing Platform

Jan 10, 2022

Singular Genomics Partners with Watchmaker Genomics to Enable the Watchmaker DNA Library Prep Kits for the G4 Sequencing Platform

Jan 10, 2022

Singular Genomics Partners with Dovetail Genomics to Enable Dovetail Kits for the G4 Sequencing Platform

Presentations & Events

Jan 12, 2022 at 1:30 PM PST

40th Annual J.P. Morgan Healthcare Conference

Nov 18, 2021 at 11:00 AM EST

Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum

Nov 09, 2021 at 1:30 PM PST

Singular Genomics Third Quarter Results and Business Update Call

Latest Earnings

Media Contacts

Dan Budwick

1AB

973-271-6085

Email Us
stock backfround image

Data provided by Refinitiv. Minimum 15 minutes delayed.